comparemela.com

Latest Breaking News On - Gilead sciences trading down - Page 6 : comparemela.com

Gilead Sciences, Inc (NASDAQ:GILD) Shares Sold by TIAA Trust National Association

Gilead Sciences, Inc (NASDAQ:GILD) Shares Sold by TIAA Trust National Association
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hartford Investment Management Co Sells 2,619 Shares of Gilead Sciences, Inc (NASDAQ:GILD)

Hartford Investment Management Co. cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 83,921 shares of the biopharmaceutical company’s stock after selling 2,619 shares during the period. Hartford Investment […]

Farmers & Merchants Investments Inc Sells 237 Shares of Gilead Sciences, Inc (NASDAQ:GILD)

Farmers & Merchants Investments Inc. trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,492 shares of the biopharmaceutical company’s stock after selling 237 shares during the period. Farmers & Merchants Investments Inc.’s […]

Pine Haven Investment Counsel Inc Trims Stock Holdings in Gilead Sciences, Inc (NASDAQ:GILD)

Pine Haven Investment Counsel Inc Trims Stock Holdings in Gilead Sciences, Inc (NASDAQ:GILD)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

4,922 Shares in Gilead Sciences, Inc (NASDAQ:GILD) Bought by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,922 shares of the biopharmaceutical company’s stock, valued at approximately $399,000. Several other institutional investors […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.